參考文獻(xiàn)
[1]Wang JG, Zhang W, Li Y, et al. Hypertension in China: epidemiology and treatment initiatives. Nat Rev Cardiol. 2023;20(8):531-545.
[2]Webb AJS, Werring DJ. New Insights Into Cerebrovascular Pathophysiology and Hypertension. Stroke. 2022;53(4):1054-1064.
[3]An SJ, Kim TJ, Yoon BW. Epidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update. J Stroke. 2017;19(1):3-10.
[4]Kuriakose D, Xiao Z. Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives. Int J Mol Sci. 2020;21(20):7609.
[5]中華醫(yī)學(xué)會神經(jīng)病學(xué)分會,中華醫(yī)學(xué)會神經(jīng)病學(xué)分會腦血管病學(xué)組. 中國急性缺血性卒中診治指南2023. 中華神經(jīng)科雜志,2024,57(06):523-559.
[6]中華醫(yī)學(xué)會神經(jīng)病學(xué)分會, 中華醫(yī)學(xué)會神經(jīng)病學(xué)分會腦血管病學(xué)組. 中國腦出血診治指南(2019). 中華神經(jīng)科雜志,2019,52 (12): 994-1005.
[7]王文志, 蓋思齊. 腦血管病的一級預(yù)防. 中華神經(jīng)科雜志, 2020, 53(8) : 614-622.
[8]中華醫(yī)學(xué)會神經(jīng)病學(xué)分會, 中華醫(yī)學(xué)會神經(jīng)病學(xué)分會腦血管病學(xué)組. 中國缺血性卒中和短暫性腦缺血發(fā)作二級預(yù)防指南2022. 中華神經(jīng)科雜志, 2022, 55(10) : 1071-1110.
[9]中華醫(yī)學(xué)會神經(jīng)病學(xué)分會,中華醫(yī)學(xué)會神經(jīng)病學(xué)分會神經(jīng)康復(fù)學(xué)組,中華醫(yī)學(xué)會神經(jīng)病學(xué)分會腦血管病學(xué)組. 中國腦卒中早期康復(fù)治療指南. 中華神經(jīng)科雜志,2017,50(6):405-412.
來源:山東疾控